Overview of workshop: In vitro dissolution of immediate release dosage forms: Development of in vivo relevance and quality control issues

Drug Information Journal

Volumn 30, Issue 4, 1996, Pages 1029-1037

  Mcgilveray, Iain J ^a  

^a Bureau of Drug Research   (Canada)

Author keywords

Capsules; Critical manufacturing variables; Dissolution; Formulation development; In vivo:in vitro correlation; Permeability; Solubility

Indexed keywords

BIOEQUIVALENCE; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DEVELOPMENT; DRUG DOSAGE FORM; DRUG DOSE; DRUG FORMULATION; DRUG INFORMATION; DRUG MANUFACTURE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; FOOD AND DRUG ADMINISTRATION; PHARMACEUTICS; PHARMACOKINETICS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TABLET;

EID: 0029852535     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159603000419     Document Type: Review

References (5)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. Biopharmaceutical Drug Classification. Pharm Res. 1995;12:413-420.
2. Qureshi SA, McGilveray IJ. A Critical Assessment of the USP Dissolution Apparatus Suitability Test Criteria Drug Dev Ind Phar. 1995;21(8):905-924.
3. Carrico CK, Workshop Report: AAPS/USP Workshop on Dissolution Calibration and Testing. Pharm Res. 1996;13:6-9.
4. Grady LT. Call for a Third Generation of Dissolution Testing and Principles of Applications - An Initial Initiative Based on Recognition of Dissolution as a Batch Characteristic. Pharmacopeial Forum. 1995; 21(1):177-180.
5. Interchangeability of Multisource pharmaceutical products. A draft report by the World Health Organization. Geneva; 1995.